The molecular and clinicopathologic characteristics of bilateral breast cancer

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Chen, S F ^a   Du, C W ^a   Yang, P ^a   Zhang, H W ^a   Kwan, M ^b   Zhang, G J ^a,c  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

BREAST NEOPLASMS; CHEMISTRY; CHINA; FEMALE; HUMAN; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PREVALENCE; RISK FACTOR; ARTICLE; BREAST TUMOR; MULTIPLE CANCER;

BREAST NEOPLASMS; CHINA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PREVALENCE; RECEPTORS, CXCR4; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883814018     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02590     Document Type: Article

References (20)

1. Schwentner, L. et al. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. Breast 21(2), 171 (2012).
2. Parker, C. C., Kim, R.H., Li, B.D.&Chu, Q. D. The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients. J Surg Oncol 106(4), 393 (2012).
3. Chen, H. W. et al. Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer. Curr Mol Med (2013).
4. Hao, L. et al. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. Cancer Lett 253(1), 34 (2007).
5. Schmid, S. M. et al. Prognosis of early-stage synchronous bilateral invasive breast cancer. Eur J Surg Oncol 37(7), 623 (2011).
6. Alkner, S. et al. Prediction of outcome after diagnosis of metachronous contralateral breast cancer. Bmc Cancer 11, 114 (2011).
7. Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824), 50 (2001).
8. Fisher, B. et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8), 567 (2002).
9. Shi, Y. X. et al. Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. J Cancer Res Clin Oncol 138(4), 705 (2012).
10. Wang, T. et al. The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer. Oncol Res 19(3-4), 171 (2011).
11. Leong, S. P. et al. Is breast cancer the same disease in Asian andWestern countries? World J Surg 34(10), 2308 (2010).
12. Metcalfe, K. et al. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9), 1384 (2011).
13. Hartman, M. et al. Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6), 377 (2005).
14. Vuoto, H. D. et al. Bilateral breast carcinoma: clinical characteristics and its impact on survival. Breast J 16(6), 625 (2010).
15. Beckmann, K. R. et al. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2), 158 (2011).
16. Kheirelseid, E. A. et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Res Treat 126(1), 131 (2011).
17. Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18), 1371 (1998).
18. Verkooijen, H. M. et al. Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 105(3), 347 (2007).
19. Diaz, R. et al. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience. Med Oncol 29(1), 16 (2012).
20. Kheirelseid, E. A. et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Res Treat 126(1), 131 (2011).